Who
Jack E. Stover
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Profusa; Director, Traws Pharma; President and CEO, Interpace Biosciences; President and CEO, Antares Pharma; Director, Arbios Systems.
In numbers
- Trades disclosed
- 83
- Buys
- 2
- Sells
- 0
- Bought
- $700
- Sold
- $0
- Companies
- 5
- Companies where not an officer
- 2
- First trade
- 16 May 2005
- Last trade
- 21 Aug 2026
- Last filed
- 4 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Aug 2026filed 4 Sep 2026 | PFSA ProfusaMedical Devices | SEC FORM 4 Code J | —32,018 at $0.00 | filing |
| 21 Aug 2026filed 4 Sep 2026 | PFSA ProfusaMedical Devices | SEC FORM 4 Code J | —301,991 at $0.00 | filing |
| 21 Aug 2026filed 4 Sep 2026 | PFSA ProfusaMedical Devices | SEC FORM 4 Code J | —32,018 at $0.00 | filing |
| 21 Aug 2026filed 4 Sep 2026 | PFSA ProfusaMedical Devices | SEC FORM 4 Code J | —301,991 at $0.00 | filing |
| 12 Aug 2026filed 19 Aug 2026 | PFSA ProfusaMedical Devices | SEC FORM 4 Code C | $1.3M301,991 at $4.28 | filing |
| 12 Aug 2026filed 19 Aug 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code C | — | filing |
| 12 Aug 2026filed 19 Aug 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code C | — | filing |
| 12 Aug 2026filed 19 Aug 2026 | PFSA ProfusaMedical Devices | SEC FORM 4 Code C | $1.3M301,991 at $4.28 | filing |
| 9 Jul 2026filed 14 Jul 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,150 at $0.00 | filing |
| 9 Jul 2026filed 14 Jul 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,150 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code P | — | filing |
| 4 May 2026filed 6 May 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code P | — | filing |
| 8 Mar 2026filed 10 Mar 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,435 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,435 at $0.00 | filing |
| 26 Jan 2026filed 30 Jan 2026 | PFSA ProfusaMedical Devices | SEC FORM 4 Code J | —553,665 | filing |
| 26 Jan 2026filed 30 Jan 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code J | —380,280 at $0.00 | filing |
| 26 Jan 2026filed 30 Jan 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code J | —380,280 at $0.00 | filing |
| 26 Jan 2026filed 30 Jan 2026 | PFSA ProfusaMedical Devices | SEC FORM 4 Code J | —553,665 | filing |
| 26 Jan 2026filed 29 Jan 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code A | —221,794 at $0.00 | filing |
| 26 Jan 2026filed 29 Jan 2026 | PFSA Profusaoption or derivative · Medical Devices | SEC FORM 4 Code A | —52,866 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.